Cipla rallies over 1% on tie-up plans UK's S&D Pharma; top Sensex gainer

NEW DELHI: Cipla Ltd rallied as much as 1.6 per cent in trade on Tuesday, a day after the pharmaceutical firm announced commercial collaboration with UK-based S&D Pharma in the Czech Republic and Slovakia.

At 09:30 a.m.; Cipla was trading 1.3 per cent higher at Rs 570.65. It hit a low of Rs 566 and a high of Rs 572.80 in trade today. The stock is also top Sensex gainer in terms of percentage return.

In a BSE filing, Cipla said this collaboration will enable it to focus on its core therapy areas, while S&D Pharma will be the key partner for generics.

Under the collaboration, Cipla will be drive its respiratory product portfolio in both Czech Republic and Slovakia through a Cipla owned sales force team, managed by Cipla commercial head, the company said in a statement.

S&D Pharma will physically distribute all products, including respiratory products, and this portfolio will increase over the next few years, it added.